MAM
EXAS

Myriad Asset Management’s Exact Sciences EXAS Stock Holding History

Myriad Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,400
Closed -$1.37M – 148
2021
Q1 		$1.37M Buy
+10,400
New +$1.42M 0.14% 82

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Myriad Asset Management's EXAS Position: Q2 2021 in Review

Myriad Asset Management sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 10,400 shares — an estimated $1.37M sold.

Myriad Asset Management first reported a position in EXAS in Q1 2021 and held it in 1 quarter. The position peaked at $1.37M in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Myriad Asset Management reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Myriad Asset Management sold 10,400 Exact Sciences shares in Q2 2021, an estimated $1.37M.
  • Myriad Asset Management first reported a position in Exact Sciences in Q1 2021 and held it in 1 quarter.
  • Myriad Asset Management's Exact Sciences position peaked at $1.37M in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Myriad Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.